Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
Meet Silvia Borras, a Development Lead and Clinical Scientist in Genetics and Molecular Pathology...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
.png)
Bioiatriki is a leading medical laboratory in Greece, providing a range of prenatal genetic testing...
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
-2.png)
The American College of Medical Genetics and Genomics (ACMG) has released an updated position...
.jpg){kind=spacer}
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...
-2.png)
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
“The first quarter of the year saw continued strong growth, record gross margin and the launching...
